Global Microbiological Testing of Water Market
完整報告名稱與涵蓋範圍
Global Microbiological Testing of Water Market Competitive Landscape and Forecast till 2035
報告摘要
The Global Microbiological Testing of Water Market Competitive Landscape and Forecast till 2035 report profiles key global life science corporations, diagnostic instrument developers, and water testing assay manufacturers. Companies compete on pathogen detection speed, assay sensitivity, automated workflow integration, regulatory agency approvals (US EPA, ISO), and reagent shelf life.
Strategic priorities center on developing field-portable rapid test kits, expanding digital reader telemetry for remote water sampling, and launching automated microfluidic PCR platforms. Strategic partnerships between laboratory equipment suppliers and municipal water utilities aim to streamline compliance testing. Vendor success through 2035 will depend on delivering rapid, certified pathogen detection solutions.
授權報價
| Single User Price | $750 USD |
| Multi User Licence (up to 10 users) | $1,000 USD |
| Enterprisewide Price (Global Site License) | $1,250 USD |
目錄 Table of Contents
TABLE OF CONTENT
1.1 INTRODUCTION 13
1.2 Company Market Share Analysis, 2025 (%) 15
1.3 COMPETITIVE BENCHMARKING 16
1.4 Comparative Analysis: Key Players Financial, 2025 17
1.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 18
1.5.1 NEW PRODUCT/SERVICE LAUNCH 18
1.5.2 MERGER AND ACQUISITION 19
1.5.3 AGREEMENT 19
1.5.4 INVESTMENT 19
2 COMPANY PROFILES 20
2.1 Thermo Fisher Scientific Inc 20
2.1.1 COMPANY OVERVIEW 20
2.1.2 FINANCIAL OVERVIEW 21
2.1.3 PRODUCTS OFFERED 21
2.1.4 KEY DEVELOPMENTS 22
2.1.5 SWOT ANALYSIS 23
2.1.6 KEY STRATEGY 23
2.2 IDEXX Laboratories, Inc 24
2.2.1 COMPANY OVERVIEW 24
2.2.2 FINANCIAL OVERVIEW 25
2.2.3 PRODUCTS OFFERED 26
2.2.4 KEY DEVELOPMENTS 26
2.2.5 SWOT ANALYSIS 27
2.2.6 KEY STRATEGY 27
2.3 Agilent Technologies, Inc 28
2.3.1 COMPANY OVERVIEW 28
2.3.2 FINANCIAL OVERVIEW 29
2.3.3 PRODUCTS OFFERED 29
2.3.4 KEY DEVELOPMENTS 30
2.3.5 SWOT ANALYSIS 30
2.3.6 KEY STRATEGY 31
2.4 Bio-Rad Laboratories, Inc 32
2.4.1 COMPANY OVERVIEW 32
2.4.2 FINANCIAL OVERVIEW 33
2.4.3 PRODUCTS OFFERED 34
2.4.4 KEY DEVELOPMENTS 34
2.4.5 SWOT ANALYSIS 35
2.4.6 KEY STRATEGY 35
2.5 Merck KGaA 36
2.5.1 COMPANY OVERVIEW 36
2.5.2 FINANCIAL OVERVIEW 37
2.5.3 PRODUCTS OFFERED 37
2.5.4 KEY DEVELOPMENTS 38
2.5.5 SWOT ANALYSIS 38
2.5.6 KEY STRATEGY 39
2.6 Hach Company 40
2.6.1 COMPANY OVERVIEW 40
2.6.2 FINANCIAL OVERVIEW 41
2.6.3 PRODUCTS OFFERED 42
2.6.4 KEY DEVELOPMENTS 42
2.6.5 SWOT ANALYSIS 43
2.6.6 KEY STRATEGY 43
2.7 bioMérieux SA 44
2.7.1 COMPANY OVERVIEW 44
2.7.2 FINANCIAL OVERVIEW 45
2.7.3 PRODUCTS OFFERED 45
2.7.4 KEY DEVELOPMENTS 46
2.7.5 SWOT ANALYSIS 46
2.7.6 KEY STRATEGY 47
2.8 Neogen Corporation 48
2.8.1 COMPANY OVERVIEW 48
2.8.2 FINANCIAL OVERVIEW 49
2.8.3 PRODUCTS OFFERED 49
2.8.4 KEY DEVELOPMENTS 50
2.8.5 SWOT ANALYSIS 50
2.8.6 KEY STRATEGY 51
2.9 Hygiena LLC 52
2.9.1 COMPANY OVERVIEW 52
2.9.2 FINANCIAL OVERVIEW 52
2.9.3 PRODUCTS OFFERED 53
2.9.4 KEY DEVELOPMENTS 53
2.9.5 SWOT ANALYSIS 54
2.9.6 KEY STRATEGY 54
2.10 R-Biopharm AG 55
2.10.1 COMPANY OVERVIEW 55
2.10.2 FINANCIAL OVERVIEW 55
2.10.3 PRODUCTS OFFERED 56
2.10.4 KEY DEVELOPMENTS 56
2.10.5 SWOT ANALYSIS 57
2.10.6 KEY STRATEGY 57
2.11 QIAGEN N.V 58
2.11.1 COMPANY OVERVIEW 58
2.11.2 FINANCIAL OVERVIEW 59
2.11.3 PRODUCTS OFFERED 59
2.11.4 KEY DEVELOPMENTS 60
2.11.5 SWOT ANALYSIS 60
2.11.6 KEY STRATEGY 61
2.12 Promega Corporation 62
2.12.1 COMPANY OVERVIEW 62
2.12.2 FINANCIAL OVERVIEW 62
2.12.3 PRODUCTS OFFERED 63
2.12.4 KEY DEVELOPMENTS 63
2.12.5 SWOT ANALYSIS 63
2.12.6 KEY STRATEGY 64
2.13 Diatheva S.R.L 65
2.13.1 COMPANY OVERVIEW 65
2.13.2 FINANCIAL OVERVIEW 65
2.13.3 PRODUCTS OFFERED 65
2.13.4 KEY DEVELOPMENTS 66
2.13.5 SWOT ANALYSIS 66
2.13.6 KEY STRATEGY 67
2.14 Hardy Diagnostics 68
2.14.1 COMPANY OVERVIEW 68
2.14.2 FINANCIAL OVERVIEW 68
2.14.3 PRODUCTS OFFERED 69
2.14.4 KEY DEVELOPMENTS 69
2.14.5 SWOT ANALYSIS 69
2.14.6 KEY STRATEGY 70
2.15 LaMotte Company 71
2.15.1 COMPANY OVERVIEW 71
2.15.2 FINANCIAL OVERVIEW 71
2.15.3 PRODUCTS OFFERED 72
2.15.4 KEY DEVELOPMENTS 72
2.15.5 SWOT ANALYSIS 73
2.15.6 KEY STRATEGY 73
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 NEW PRODUCT/SERVICE LAUNCH 1
TABLE 2 MERGER AND ACQUISITION 1
TABLE 3 AGREEMENT 1
TABLE 4 INVESTMENT 1
TABLE 5 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 1
TABLE 6 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS 1
TABLE 7 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED 1
TABLE 8 IDEXX LABORATORIES, INC.: KEY DEVELOPMENTS 1
TABLE 9 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 1
TABLE 10 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS 1
TABLE 11 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 1
TABLE 12 BIO-RAD LABORATORIES, INC.: KEY DEVELOPMENTS 1
TABLE 13 MERCK KGAA: PRODUCTS OFFERED 1
TABLE 14 MERCK KGAA: KEY DEVELOPMENTS 1
TABLE 15 HACH COMPANY: PRODUCTS OFFERED 1
TABLE 16 HACH COMPANY: KEY DEVELOPMENTS 1
TABLE 17 BIOMÉRIEUX SA: PRODUCTS OFFERED 1
TABLE 18 BIOMÉRIEUX SA: KEY DEVELOPMENTS 1
TABLE 19 NEOGEN CORPORATION: PRODUCTS OFFERED 1
TABLE 20 NEOGEN CORPORATION: KEY DEVELOPMENTS 1
TABLE 21 HYGIENA LLC: PRODUCTS OFFERED 1
TABLE 22 R-BIOPHARM AG: PRODUCTS OFFERED 1
TABLE 23 QIAGEN N.V.: PRODUCTS OFFERED 1
TABLE 24 PROMEGA CORPORATION: PRODUCTS OFFERED 1
TABLE 25 DIATHEVA S.R.L.: PRODUCTS OFFERED 1
TABLE 26 HARDY DIAGNOSTICS: PRODUCTS OFFERED 1
TABLE 27 LAMOTTE COMPANY: PRODUCTS OFFERED 1
LIST OF FIGURES
FIGURE 1 GLOBAL MICROBIOLOGICAL TESTING OF WATER MAJOR PLAYERS MARKET SHARE ANALYSIS, 2025 (%) 1
FIGURE 2 BENCHMARKING OF MAJOR COMPETITORS 1
FIGURE 3 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL, 2025 1
FIGURE 4 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 5 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 1
FIGURE 6 IDEXX LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 7 IDEXX LABORATORIES, INC.: SWOT ANALYSIS 1
FIGURE 8 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 9 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS 1
FIGURE 10 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 11 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS 1
FIGURE 12 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 13 MERCK KGAA: SWOT ANALYSIS 1
FIGURE 14 HACH COMPANY: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 15 HACH COMPANY: SWOT ANALYSIS 1
FIGURE 16 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 17 BIOMÉRIEUX SA: SWOT ANALYSIS 1
FIGURE 18 NEOGEN CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 19 NEOGEN CORPORATION: SWOT ANALYSIS 1
FIGURE 20 HYGIENA LLC: SWOT ANALYSIS 1
FIGURE 21 R-BIOPHARM AG: SWOT ANALYSIS 1
FIGURE 22 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT 1
FIGURE 23 QIAGEN N.V.: SWOT ANALYSIS 1
FIGURE 24 PROMEGA CORPORATION: SWOT ANALYSIS 1
FIGURE 25 DIATHEVA S.R.L.: SWOT ANALYSIS 1
FIGURE 26 HARDY DIAGNOSTICS: SWOT ANALYSIS 1
FIGURE 27 LAMOTTE COMPANY: SWOT ANALYSIS 1
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們